ConductScience.org, home

Paper34095367

Clinical trial of autologous adipose tissue-derived regenerative (stem) cells therapy for exploration of its safety and efficacy.

Sakai Y and 23 others. Regen Ther, 2021. Cited by 18 papers, by iCite.

Cite this record

ConductScience Library. Clinical trial of autologous adipose tissue-derived regenerative (stem) cells therapy for exploration of its safety and efficacy. Papers, record 34095367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34095367

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Clinical trial of autologous adipose tissue-derived regenerative (stem) cells therapy for exploration of its safety and efficacy.
PubMed
Journal
Regen Ther
PubMed
Year
2021
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
18
iCite
Relative citation ratio, by iCite
1.23
iCite
Revised in PubMed
2022-04-23
PubMed

Authors24

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sakai YYoshio
2Fukunishi SShinya
3Takamura MMasayuki
4Kawaguchi KKazunori
5Inoue OOto
6Usui SSoichiro
7Takashima SShinichiro
8Seki AAkihiro
9Asai AAkira
10Tsuchimoto YYusuke
11Nasti AAlessandro
12Bich Ho TTTuyen Thuy
13Imai YYasuhito
14Yoshimura KKenichi
15Murayama TToshinori
16Yamashita TTaro
17Arai KKuniaki
18Yamashita TTatsuya
19Mizukoshi EEishiro
20Honda MMasao

Source PubMed

See all 24 authorsDownload CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References26

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118328931Liver cirrhosis.Lancet2008https://conductscience.org/library/papers/18328931PubMed
228891216The CD45+ fraction in murine adipose tissue derived stromal cells harbors immune-inhibitory inflammatory cells.Eur J Immunol2017https://conductscience.org/library/papers/28891216PubMed
329181853Toward the elimination of hepatitis C in the United States.Hepatology2018https://conductscience.org/library/papers/29181853PubMed
49804556Embryonic stem cell lines derived from human blastocysts.Science1998https://conductscience.org/library/papers/9804556PubMed
57242681Establishment in culture of pluripotential cells from mouse embryos.Nature1981https://conductscience.org/library/papers/7242681PubMed
617495232Adipose-derived stem cells for regenerative medicine.Circ Res2007https://conductscience.org/library/papers/17495232PubMed
731981519The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.Lancet Gastroenterol Hepatol2020https://conductscience.org/library/papers/31981519PubMed
813951335The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles.J Embryol Exp Morphol1962https://conductscience.org/library/papers/13951335PubMed
910348825Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.Gastroenterology1999https://conductscience.org/library/papers/10348825PubMed
1028555267Long-term outcome of adipose-derived regenerative cell-enriched autologous fat transplantation for reconstruction after breast-conserving surgery for Japanese women with breast cancer.Surg Today2017https://conductscience.org/library/papers/28555267PubMed
1126566246Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta-analysis.Hepatology2016https://conductscience.org/library/papers/26566246PubMed
1219304117Autologous adipose tissue as a new source of progenitor cells for therapeutic angiogenesis.J Cardiol2009https://conductscience.org/library/papers/19304117PubMed
1330271839Phase I clinical study of liver regenerative therapy for cirrhosis by intrahepatic arterial infusion of freshly isolated autologous adipose tissue-derived stromal/stem (regenerative) cell.Regen Ther2017https://conductscience.org/library/papers/30271839PubMed
1416904174Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.Cell2006https://conductscience.org/library/papers/16904174PubMed
1526707365Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.Hepatology2016https://conductscience.org/library/papers/26707365PubMed
1618220880Adult mesenchymal stem cells: a pluripotent population with multiple applications.Curr Stem Cell Res Ther2006https://conductscience.org/library/papers/18220880PubMed
1711304456Multilineage cells from human adipose tissue: implications for cell-based therapies.Tissue Eng2001https://conductscience.org/library/papers/11304456PubMed
1823934743Adipose tissue derived stromal stem cell therapy in murine ConA-derived hepatitis is dependent on myeloid-lineage and CD4+ T-cell suppression.Eur J Immunol2013https://conductscience.org/library/papers/23934743PubMed
1921319198Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings.Hepatology2011https://conductscience.org/library/papers/21319198PubMed
2021038418Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis.Hepatology2010https://conductscience.org/library/papers/21038418PubMed

See all 26 referencesDownload CSV of references

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.

PMIDTitleJournalYearIn PapersSource
42216085Mesenchymal stem cells and extracellular vesicles for MAFLD: from biological mechanisms to translational prospects.Stem Cell Res Ther2026https://conductscience.org/library/papers/42216085PubMed
41457250Cryogenic microcarrier-assisted stem cell storage (Cryo-MASCS): a preservation method enabling scalable culture of human mesenchymal stem cells.Stem Cell Res Ther2025https://conductscience.org/library/papers/41457250PubMed
40061260Induced pluripotent stem cell-derived mesenchymal stem cells for modeling and treating metabolic associated fatty liver disease and metabolic associated steatohepatitis: Challenges and opportunities.World J Stem Cells2025https://conductscience.org/library/papers/40061260PubMed
39789253Intra-Arterial Stem Cell Injection for Treating Various Diseases: A New Frontier in Interventional Radiology.Cardiovasc Intervent Radiol2025https://conductscience.org/library/papers/39789253PubMed
39351260Innovative mesenchymal stem cell treatments for fatty liver disease.World J Stem Cells2024https://conductscience.org/library/papers/39351260PubMed
39273207New Insights into Adipose Tissue Metabolic Function and Dysfunction, 2nd Edition.Int J Mol Sci2024https://conductscience.org/library/papers/39273207PubMed
39135088Examining the potentials of stem cell therapy in reducing the burden of selected non-communicable diseases in Africa.Stem Cell Res Ther2024https://conductscience.org/library/papers/39135088PubMed
38337604Trans-Arterial Stem Cell Injection (TASI): The Role of Interventional Radiology in Regenerative Medicine.J Clin Med2024https://conductscience.org/library/papers/38337604PubMed
38028938Lipoaspirate stored at a constant low temperature by electric control suppresses intracellular metabolism and maintains high cell viability.Regen Ther2023https://conductscience.org/library/papers/38028938PubMed
38002056Hepatic Macrophages as Targets for the MSC-Based Cell Therapy in Non-Alcoholic Steatohepatitis.Biomedicines2023https://conductscience.org/library/papers/38002056PubMed
37667383Enhancing mesenchymal stem cell survival and homing capability to improve cell engraftment efficacy for liver diseases.Stem Cell Res Ther2023https://conductscience.org/library/papers/37667383PubMed
37108631Gene Therapy Based on Mesenchymal Stem Cells Derived from Adipose Tissue for the Treatment of Obesity and Its Metabolic Complications.Int J Mol Sci2023https://conductscience.org/library/papers/37108631PubMed
37064607Curcumin Nanofiber PCL/PLGA/Collagen Enhanced the Therapeutic Efficacy of Mesenchymal Stem Cells against Liver Fibrosis in Animal Model and Prevented its Recurrence.Nanotheranostics2023https://conductscience.org/library/papers/37064607PubMed
36010561Cellular Therapies in Pediatric Liver Diseases.Cells2022https://conductscience.org/library/papers/36010561PubMed
35933430Stem cell-based therapy for human diseases.Signal Transduct Target Ther2022https://conductscience.org/library/papers/35933430PubMed
35915364Adult Stem Cell Therapy as Regenerative Medicine for End-Stage Liver Disease.Adv Exp Med Biol2022https://conductscience.org/library/papers/35915364PubMed
34926735Characterization of adipose tissue-derived stromal cells of mice with nonalcoholic fatty liver disease and their use for liver repair.Regen Ther2021https://conductscience.org/library/papers/34926735PubMed

Download CSV of cited by

Genes8

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34095367

GET https://conductscience.org/api/papers/v1/34095367/authors?page=2